Research ArticleSpondyloarthritis
The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort
Jean W. Liew, S. Reza Jafarzadeh, Maureen Dubreuil, Susan R. Heckbert, Stephen J. Mooney, Matthew A. Brown, Mariko L. Ishimori, John D. Reveille, Michael M. Ward, Michael H. Weisman and Lianne S. Gensler
The Journal of Rheumatology March 2022, 49 (3) 274-280; DOI: https://doi.org/10.3899/jrheum.210332
Jean W. Liew
1J.W. Liew, MD, MS, S.R. Jafarzadeh, PhD, M. Dubreuil, MD, MSc, Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA;
S. Reza Jafarzadeh
1J.W. Liew, MD, MS, S.R. Jafarzadeh, PhD, M. Dubreuil, MD, MSc, Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA;
Maureen Dubreuil
1J.W. Liew, MD, MS, S.R. Jafarzadeh, PhD, M. Dubreuil, MD, MSc, Section of Rheumatology, Boston University School of Medicine, Boston, Massachusetts, USA;
Susan R. Heckbert
2S.R. Heckbert, MD, PhD, Cardiovascular Health Research Unit and Department of Epidemiology, University of Washington, Seattle, Washington, USA;
Stephen J. Mooney
3S.J. Mooney, PhD, Department of Epidemiology, University of Washington, Seattle, Washington, USA;
Matthew A. Brown
4M.A. Brown, MBBS, MD, FRACP, FAHSM, FAA, King’s College London and Guy’s and St Thomas’ NHS Foundation Trust and King’s College London NIHR Biomedical Research Centre, London, UK;
Mariko L. Ishimori
5M.L. Ishimori, MD, Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA;
John D. Reveille
6J.D. Reveille, MD, Division of Rheumatology and Clinical Immunogenetics, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, Texas, USA;
Michael M. Ward
7M.M. Ward, MD, MPH, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA;
Michael H. Weisman
8M.H. Weisman, MD, Division of Rheumatology, Cedars-Sinai Medical Center, and David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA;
Lianne S. Gensler
9L.S. Gensler, MD, Department of Medicine/Rheumatology, Russell Engleman Rheumatology Research Center, University of California San Francisco, San Francisco, California, USA.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 49, Issue 3
1 Mar 2022
The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort
Jean W. Liew, S. Reza Jafarzadeh, Maureen Dubreuil, Susan R. Heckbert, Stephen J. Mooney, Matthew A. Brown, Mariko L. Ishimori, John D. Reveille, Michael M. Ward, Michael H. Weisman, Lianne S. Gensler
The Journal of Rheumatology Mar 2022, 49 (3) 274-280; DOI: 10.3899/jrheum.210332
The Association of Tumor Necrosis Factor Inhibitor Use With Incident Hypertension in Ankylosing Spondylitis: Data From the PSOAS Cohort
Jean W. Liew, S. Reza Jafarzadeh, Maureen Dubreuil, Susan R. Heckbert, Stephen J. Mooney, Matthew A. Brown, Mariko L. Ishimori, John D. Reveille, Michael M. Ward, Michael H. Weisman, Lianne S. Gensler
The Journal of Rheumatology Mar 2022, 49 (3) 274-280; DOI: 10.3899/jrheum.210332